Transcatheter Aortic Valve Replacement In Moderate-Risk Aortic Stenosis Patients

Journal
Article on Transcatheter Aortic Valve Replacement In Moderate-Risk Aortic Stenosis Patients

Add this Moment to your Passport

Learn from this moment and keep it forever.
FREE
Add To Passport

Overview

The Placement of Aortic Transcatheter Valves (PARTNER) trial showed the effectiveness of transcatheter aortic valve replacement (TAVR) for inoperable patients and non-inferiority for mortality versus open valve replacement. There are three questions concerning the role of TAVR for intermediate-risk patients. These relate to: institutional and surgeon results, physician and hospital alignments, and who will pay.

Featuring

Lars G Svensson - Department of Cardiothoracic Surgery, Aorta Center and Heart and Vascular Institute, Cleveland, US

Loading Simple Education